Hypocalcaemia is imbalance of electrolytes which is indicated by abnormally low level of calcium in the body. A healthy person has 8.5-10.2 mg/dL calcium level in his/her body, however, drop in this level could possibly led to hypocalcaemia disorder. Middle aged population needs to take 1000 mg of calcium while geriatrics population aged 65 and above should take 1500 mg of calcium per day. Hypocalcaemia is caused by hypoalbuminemia, hyperphosphatemia, surgical effects, medication effects, hypomagnesemia, heart failure, muscle cramps, vitamin D deficiency, alcoholism, magnesium deficiency, insufficient protein in the blood, in the blood and many more. Neuromuscular irritability is the most common sign of hypocalcaemia. Hypocalcaemia are mostly diagnosed by clinical suspicion and laboratory testing. Hypoparathyroidism has a major effect on hypocalcaemia and high recurrence rate.

The hypocalcaemia can be caused at any age but it is commonly observed in ill patients and patients with parathyroid surgery and with increase in the prevalence of heat related disorders in the older population witnessing the growth of hypocalcaemia treatment market is expected to expand at considerable CAGR during the forecasted period. Also, with increase in the awareness among the aging population and availability of treatment creates an opportunity for hypocalcaemia treatment market worldwide. However, the biochemical abnormality associated with hypocalcaemia carries risks in diagnosis and treatment.

The Hypocalcaemia Treatment Market has been classified on the basis of product, application, end use and geography.

Hypocalcaemia Treatment Market by type:

Asymptomatic
Symptomatic
Prophylactic

Hypocalcaemia Treatment Market by Drug type:

Radiocontrast
Loop diuretics
Calcium supplements
Antibiotics
Antiepileptic drugs
Estrogen
Bisphosphonates
Cinacalcet

Hypocalcaemia Treatment Market by dosage forms type:

Calcium supplements
Parenteral preparation
Oral preparation
Vitamin D supplements
Parenteral preparation
Oral preparation

Parenteral calcium supplements dosage are given to patients suffering from acute hypocalcaemia. Whereas, in case of chronic hypocalcaemia oral calcium supplements are administered. Medical supervision is given to avoid risk associated with parenteral administration. With increasing demand for effective treatment of hypocalcemia, companies need to capitalize on their resources to offer effective medications and in turn further expand their business footprint in developing regions.

Interested in report: Please follow the below links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/9650

Depending on geographic region, hypocalcaemia treatment market is segmented into seven key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Incidence rate of hypocalcaemia is quite high in North America compared to other regions. North America dominates the global hypocalcaemia treatment market followed by Europe, Asia Pacific owing to high awareness about the treatments of hypocalcaemia in these regions. The developing regions such as Asia Pacific, Middle East & Africa hold huge potential and is a promising market for hypocalcaemia treatment due to significant increase in medical tourism industry.

Request TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/9650

Key players of Hypocalcaemia Treatment Market are F. Hoffman La Roche, Novo Nordisk, Sanofi, GlaxoSmithKline (GSK), Pfizer Inc., and Ranbaxy Pharmaceuticals Ltd.

For more info: http://www.persistencemarketresearch.com/contact-us.asp

The report covers exhaustive analysis on:

Hypocalcaemia Treatment Market Segments
Hypocalcaemia Treatment Market Dynamics
Historical Actual Market Size, 2013 - 2015
Hypocalcaemia Treatment Market Size & Forecast 2016 to 2022
Hypocalcaemia Treatment Market Current Trends/Issues/Challenges
Competition & Companies involved
Hypocalcaemia Treatment Market Drivers and Restraints

Regional analysis includes

North America
Latin America
Europe
Asia Pacific
Middle East and Africa

Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size
Recent industry trends
Key Competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

About Us

Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States
USA - Canada Toll Free: +1 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com